Active Not RecruitingNCT04733534
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
PHASE2 · 120 planned enrolment
- Countries listed
- 1
- Registry update
- September 30, 2026
immortal.lifeTrial registrations containing the exact intervention label Fisetin.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Only exact preferred-label or exact synonym matches are shown. Similar names are not treated as the same substance.
PHASE2 · 120 planned enrolment
PHASE2 · 34 planned enrolment
PHASE2 · 20 planned enrolment
PHASE2 · 74 planned enrolment
PHASE1 · PHASE2 · 68 planned enrolment
PHASE1 · PHASE2 · 100 planned enrolment